Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab placebo-controlled imaging study in adults with asthma
2019-004647-74Phase 4Unknown
- Sponsor
- Sanofi
- Start
- Apr 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Dupixent with Placebo (2 arms). Primary endpoint: Change from baseline to Week 24 in pre-bronchodilator FEV1. Status: unknown.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on 2019-004647-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004647-74.